UK markets close in 6 hours 23 minutes

Aerie Pharmaceuticals, Inc. (AERI)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
10.64+0.42 (+4.11%)
At close: 04:00PM EST
10.64 0.00 (0.00%)
After hours: 05:29PM EST
Full screen
Trade prices are not sourced from all markets
Previous close10.22
Open10.27
Bid0.00 x 1800
Ask0.00 x 1000
Day's range10.04 - 10.67
52-week range9.15 - 21.30
Volume799,359
Avg. volume981,256
Market cap503.884M
Beta (5Y monthly)0.85
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • Business Wire

    Aerie Concludes Exclusive License Agreement With Santen for Rhopressa® and Rocklatan® in Europe and Several Other Regions

    DURHAM, N.C., December 07, 2021--Aerie Pharmaceuticals, Inc. (NASDAQ: AERI, "Aerie") announced that Aerie and Santen have entered into an exclusive development and commercialization agreement for Rhopressa®/Rhokiinsa® (netarsudil ophthalmic solution) 0.02% and Rocklatan®/Roclanda® (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005%. The expanded collaboration includes Europe, Commonwealth of Independent States (CIS) countries, China, India, parts of Latin America and the Oceania countr

  • Business Wire

    Aerie Pharmaceuticals to Participate in Upcoming Investor Conferences

    DURHAM, N.C., November 09, 2021--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases, today announced that the Benjamin McGraw, III, Pharm.D., Interim Executive Chairman, will participate in the following virtual investor conferences.

  • Business Wire

    Aerie Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update

    DURHAM, N.C., November 04, 2021--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company, today reported financial results for the third quarter ended September 30, 2021 and provided a general business update.